Indian Pharma Network (IPN)
Medicines For Pancreatic Cancer Treatment
IPN, New Delhi can facilitate Pancreatic cancer patient to “import of Medicines For Pancreatic Cancer Treatment” for personal use under “patient name basis” treatment in India. For this applicant is required to make an request application with required document. IPN, New Delhi will do the necessary process to obtain permission from Drugs Controller General (India) to import.
Indian Pharma Network
M: +91-9891296838 / 9811747774
E: med@indianpharmanetwork.co.in
Pancreatic Cancer Treatment
Pancreatic cancer is a type of cancer that starts in the cells of the pancreas, an organ located behind the stomach that produces digestive enzymes and hormones such as insulin and glucagon. Pancreatic cancer can be classified into two main types: exocrine pancreatic cancer and endocrine pancreatic cancer.
Exocrine pancreatic cancer is the most common type, accounting for more than 95% of cases. It starts in the cells that produce digestive enzymes and can spread rapidly to nearby organs and tissues. Endocrine pancreatic cancer, also known as neuroendocrine tumors, is much less common and starts in the cells that produce hormones such as insulin.
Get Access FDA Approved Medicines For Pancreatic Cancer Treatment
The treatment of pancreatic cancer often involves a combination of approaches, which may include surgery, radiation therapy, chemotherapy, targeted therapy, or a combination of these treatments. The choice of treatment will depend on the stage and location of the cancer, as well as the overall health of the patient. Here are some of the medications that may be used to treat pancreatic cancer:
Chemotherapy is a common treatment for pancreatic cancer, which is a type of cancer that starts in the pancreas. The following are some chemotherapy medications that may be used to treat pancreatic cancer:
- Gemcitabine (Gemzar):
This is a chemotherapy drug that is often used as a first-line treatment for pancreatic cancer. It is usually given by injection into a vein. - FOLFIRINOX:
This is a combination of four chemotherapy drugs: 5-fluorouracil (5-FU), leucovorin, irinotecan, and oxaliplatin. It is typically used for people with advanced pancreatic cancer who are in good physical condition. - Abraxane (Paclitaxel protein-bound particles for injectable suspension):
This chemotherapy drug is a protein-bound form of paclitaxel. It is often used in combination with gemcitabine for the treatment of metastatic pancreatic cancer. - 5-fluorouracil (5-FU):
This is a chemotherapy drug that has been used for many years to treat pancreatic cancer. It is usually given by injection into a vein. - Cisplatin:
This is a chemotherapy drug that is sometimes used in combination with gemcitabine for the treatment of pancreatic cancer.
It’s important to note that the choice of chemotherapy drugs used to treat pancreatic cancer depends on various factors, including the stage and location of the cancer, as well as the overall health of the patient. Your healthcare provider will determine the most appropriate treatment plan for you.
Targeted therapy is a type of cancer treatment that uses drugs to target specific molecules or pathways that are involved in the growth and spread of cancer cells. The following are some targeted therapy medications that may be used to treat pancreatic cancer:
- Erlotinib (Tarceva):
This medication is an epidermal growth factor receptor (EGFR) inhibitor that is often used in combination with gemcitabine for the treatment of advanced pancreatic cancer. - Bevacizumab (Avastin):
This medication is a vascular endothelial growth factor (VEGF) inhibitor that works by blocking the growth of blood vessels that feed tumors. It is sometimes used in combination with chemotherapy for the treatment of advanced pancreatic cancer. - Atezolizumab (Tecentriq):
This medication is an immune checkpoint inhibitor that works by stimulating the immune system to attack cancer cells. It is sometimes used in combination with chemotherapy for the treatment of advanced pancreatic cancer. - Olaparib (Lynparza): This medication is a PARP inhibitor that works by blocking an enzyme called PARP, which cancer cells use to repair DNA damage. It is sometimes used as a maintenance therapy for patients with metastatic pancreatic cancer who have a BRCA mutation.
It’s important to note that the use of targeted therapy medications for pancreatic cancer is generally limited to patients with specific genetic mutations or biomarkers. Your healthcare provider will determine the most appropriate treatment plan for you based on your individual case.
Immunotherapy is a type of cancer treatment that works by stimulating the immune system to recognize and attack cancer cells. The following are some immunotherapy medications that may be used to treat pancreatic cancer:
- Pembrolizumab (Keytruda):
This medication is a programmed cell death protein 1 (PD-1) inhibitor that works by blocking the interaction between PD-1 and its ligands, which can suppress the immune system. It is sometimes used in combination with chemotherapy for the treatment of advanced pancreatic cancer. - Nivolumab (Opdivo):
This medication is also a PD-1 inhibitor that works in a similar way to pembrolizumab. It is sometimes used in combination with chemotherapy for the treatment of advanced pancreatic cancer. - Ipilimumab (Yervoy):
This medication is a cytotoxic T-lymphocyte antigen 4 (CTLA-4) inhibitor that works by blocking the interaction between CTLA-4 and its ligands, which can also suppress the immune system. It is sometimes used in combination with nivolumab for the treatment of advanced pancreatic cancer. - Durvalumab (Imfinzi):
This medication is a programmed cell death ligand 1 (PD-L1) inhibitor that works by blocking the interaction between PD-L1 and its receptors, which can suppress the immune system. It is sometimes used in combination with chemotherapy for the treatment of advanced pancreatic cancer.
It’s important to note that the use of immunotherapy medications for pancreatic cancer is generally limited to patients with specific biomarkers or genetic mutations. Your healthcare provider will determine the most appropriate treatment plan for you based on your individual case.
Radiation therapy uses high-energy radiation to kill cancer cells. It may be used before or after surgery, or in combination with chemotherapy. Radiation therapy can help to shrink tumors and relieve symptoms of pancreatic cancer.
It’s important to note that treatment plans for pancreatic cancer are highly individualized, and the medications and treatments used will depend on the stage and location of the cancer, as well as the overall health of the patient. It’s best to consult with an oncologist to determine the most appropriate treatment plan for your specific case.
Legitimate Healthcare Consultant and Facilitator In Delhi
If you have a question relating to anti-cancer medicines approved for treatment of Pancreatic Cancer, a problem which you do not know how to resolve it, or concrete inquiry – we are here for you. We will answer you via email urgent@indianpharmanetwork.co.in as soon as possible. If you prefer to be contacted by phone, please leave your phone number. Or text your message in WhatsApp Number +91 9891296838 / 9811747774.
Contact Info
CORPORATE OFFICE:
Basement-B-5-A, Ajit Singh House Building No.12, Yusuf Sarai, South Delhi,
New Delhi:110016 India.
MOBILE / PHONE NUMBER:
M: +91 9811747774, 9891296838.
P / F: +91-11-26532129 / 26536398
EMAIL ID:
info@indianpharmanetwork.co.in
FAX NUMBER:
+91-11-26532129
Query Form For Medications
Indian Pharma Network (IPN), New Delhi. India
Indian Pharma Network (IPN) is registered organisation in India, having highly qualified healthcare professionals of pharmaceutical Industry. Specialized in Oncology Products. Helped more than 6,000 patients. Registration Number : 07AAFFI2544E1ZO under GST Act.
Branch Offices in India : New Delhi | Bengaluru | Kolkata | Lucknow | Jaipur | Jodhpur.
Our Overseas Network UK | Russia | Brazil | Mexico | Germany | France| Italy | Spain | Japan | China| Australia | Brazil | Saudi Arabia | South Africa
Mobile / WhatsApp / Phone
M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398
Free Customer Support
info@ipnintl.com
urgent@ipnintl.com